RKT.L

Reckitt Benckiser Group Plc
Reckitt Benckiser Gp - COMPLETION OF SHARE BUYBACK PROGRAMME
1st July 2025, 06:02
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 0772P
Reckitt Benckiser Group PLC
01 July 2025
 

RECKITT BENCKISER GROUP PLC

 

COMPLETION OF SHARE BUYBACK PROGRAMME

 

 

Reckitt Benckiser Group plc ("Reckitt" or the "Company") confirms the successful completion of the third and final tranche of its current £1 billion share buyback programme (the "Third Tranche") announced on 9 December 2024.

 

Under the Third Tranche, between 12 December 2024 and 30 June 2025, the Company has purchased 9,920,979 ordinary shares of 10p each (the "Ordinary Shares") at an average price of £50.40, and which are now held in treasury.

 

Aligned with the Company's capital allocation policy and ongoing commitment to returning surplus cash to shareholders, Reckitt intends to announce a new buyback programme alongside the Company's HY 2025 results, scheduled for 24 July 2025.

 

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

 

CONTACT DETAILS:

 

Contacts

 

Nick Ashworth                                                    +44 (0) 7408 812350

Investor Relations

 

Catheryn O'Rourke                                             +44 (0) 1753 217 800

General Counsel & Company Secretary

 

 

About Reckitt*:

 

We make the products people trust to care for the ones they love. We are home to some of the world's best-loved consumer health and hygiene brands, including Dettol, Durex, Finish, Gaviscon, Harpic, Lysol, Mucinex, Nurofen, Strepsils, Vanish and Veet. Consumers are at the heart of everything we do. By creating innovative, science-backed solutions, we support people every day to live healthier lives.

 

Reckitt exists to protect, heal and nurture in the pursuit of a cleaner, healthier world. This commitment goes beyond the products we make. Through our actions, we expand access to healthcare, education and economic opportunities. We support the planet by reducing waste, conserving resources and driving sustainable innovation.

 

We believe good health starts at home. With every action we take, we strive to make our consumers' lives easier, cleaner and healthier, to strengthen communities and to create a more sustainable future.

 

Find out more or get in touch with us at www.reckitt.com.

 

* Reckitt is the trading name of the Reckitt Benckiser group of companies

 

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCWPUPPQUPAGMU]]>
TwitterFacebookLinkedIn